Cargando…
Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
Introduction: Immunotherapy is a treatment option for non-small cell lung cancer advanced disease. However; immunotherapy in several patients induces orogonitis and effusion in different cavities. It is up to the treating physician to understand whether there is effusion due to adverse effect or dis...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995373/ https://www.ncbi.nlm.nih.gov/pubmed/32047566 http://dx.doi.org/10.7150/jca.40004 |
_version_ | 1783493368861425664 |
---|---|
author | Zarogoulidis, Paul Huang, Haidong Yang, Meng Zhou, Jun Jiao, Yang Wang, Qin Petridis, Dimitris Sapalidis, Konstantinos Sardeli, Chrysanthi Konsta, Parthenopi Koulouris, Charilaos Michalopoulos, Nikolaos Giannakidis, Dimitrios Barbetakis, Nikolaos Katsaounis, Athanasios Hohenforst-Schmidt, Wolfgang Amaniti, Aikaterini Petanidis, Savvas Tsakiridis, Kosmas Courcoutsakis, Nikolaos Goganau, Alexandru Marian Vagionas, Anastasios Romanidis, Konstantinos Oikonomou, Panagoula Karanikas, Michael Katsios, Iason Nikolaos Kesisoglou, Isaak Kosmidis, Christoforos |
author_facet | Zarogoulidis, Paul Huang, Haidong Yang, Meng Zhou, Jun Jiao, Yang Wang, Qin Petridis, Dimitris Sapalidis, Konstantinos Sardeli, Chrysanthi Konsta, Parthenopi Koulouris, Charilaos Michalopoulos, Nikolaos Giannakidis, Dimitrios Barbetakis, Nikolaos Katsaounis, Athanasios Hohenforst-Schmidt, Wolfgang Amaniti, Aikaterini Petanidis, Savvas Tsakiridis, Kosmas Courcoutsakis, Nikolaos Goganau, Alexandru Marian Vagionas, Anastasios Romanidis, Konstantinos Oikonomou, Panagoula Karanikas, Michael Katsios, Iason Nikolaos Kesisoglou, Isaak Kosmidis, Christoforos |
author_sort | Zarogoulidis, Paul |
collection | PubMed |
description | Introduction: Immunotherapy is a treatment option for non-small cell lung cancer advanced disease. However; immunotherapy in several patients induces orogonitis and effusion in different cavities. It is up to the treating physician to understand whether there is effusion due to adverse effect or disease progression. Pleurodesis in both cases might be a solution for recurrent pleura effusion. Patients and Methods: Three hundred and thirty seven non-small cell lung cancer patients with adenocarcinoma and pleura effusion during first line immunotherapy treatment underwent medical thoracoscopy or Video assisted thoracic surgery (VATS) for pleurodesis with talk poudrage. Uniportal medical thoracoscopy was performed under general with dual channel endotracheal tube in one hundred and eleven patients. Video assisted thoracic surgery was performed in one hundred and eighty seven patients and conversion from medical to VATS procedure was done to thirty nine patients. All patients had stage IV disease with pleura involvement and were under first line pembrolizumab treatment with 200mg (PD-L1 ≥ 50%). Results: The quantitative parameters of the study (expression, PY and cycle) were converted to an ordinal scale to facilitate the performance of statistical analysis. All parameters were examined as dependent against the parameter technique acting as independent to detect potential relationships. The results of multi Y versus X relationship revealed no statistically significant effect (p>0.05) of the three levels of technique against any response considered. Thus we can infer, quite safely, that the innovative operation (level 0) does not differ from the other two conventional methods (levels 2 and 3) through all parameters entered in the model. There was no significant difference between the different pleurodesis techniques. Discussion: Immunotherapy is known to induce in a number of patients pleura effusion and pericarditis. However; pleurodesis is efficient when the appropriate method is performed to every patient. Careful assessment in a case by case manner has to be performed for each patient before any procedure is performed. |
format | Online Article Text |
id | pubmed-6995373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-69953732020-02-11 Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? Zarogoulidis, Paul Huang, Haidong Yang, Meng Zhou, Jun Jiao, Yang Wang, Qin Petridis, Dimitris Sapalidis, Konstantinos Sardeli, Chrysanthi Konsta, Parthenopi Koulouris, Charilaos Michalopoulos, Nikolaos Giannakidis, Dimitrios Barbetakis, Nikolaos Katsaounis, Athanasios Hohenforst-Schmidt, Wolfgang Amaniti, Aikaterini Petanidis, Savvas Tsakiridis, Kosmas Courcoutsakis, Nikolaos Goganau, Alexandru Marian Vagionas, Anastasios Romanidis, Konstantinos Oikonomou, Panagoula Karanikas, Michael Katsios, Iason Nikolaos Kesisoglou, Isaak Kosmidis, Christoforos J Cancer Research Paper Introduction: Immunotherapy is a treatment option for non-small cell lung cancer advanced disease. However; immunotherapy in several patients induces orogonitis and effusion in different cavities. It is up to the treating physician to understand whether there is effusion due to adverse effect or disease progression. Pleurodesis in both cases might be a solution for recurrent pleura effusion. Patients and Methods: Three hundred and thirty seven non-small cell lung cancer patients with adenocarcinoma and pleura effusion during first line immunotherapy treatment underwent medical thoracoscopy or Video assisted thoracic surgery (VATS) for pleurodesis with talk poudrage. Uniportal medical thoracoscopy was performed under general with dual channel endotracheal tube in one hundred and eleven patients. Video assisted thoracic surgery was performed in one hundred and eighty seven patients and conversion from medical to VATS procedure was done to thirty nine patients. All patients had stage IV disease with pleura involvement and were under first line pembrolizumab treatment with 200mg (PD-L1 ≥ 50%). Results: The quantitative parameters of the study (expression, PY and cycle) were converted to an ordinal scale to facilitate the performance of statistical analysis. All parameters were examined as dependent against the parameter technique acting as independent to detect potential relationships. The results of multi Y versus X relationship revealed no statistically significant effect (p>0.05) of the three levels of technique against any response considered. Thus we can infer, quite safely, that the innovative operation (level 0) does not differ from the other two conventional methods (levels 2 and 3) through all parameters entered in the model. There was no significant difference between the different pleurodesis techniques. Discussion: Immunotherapy is known to induce in a number of patients pleura effusion and pericarditis. However; pleurodesis is efficient when the appropriate method is performed to every patient. Careful assessment in a case by case manner has to be performed for each patient before any procedure is performed. Ivyspring International Publisher 2020-01-14 /pmc/articles/PMC6995373/ /pubmed/32047566 http://dx.doi.org/10.7150/jca.40004 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Zarogoulidis, Paul Huang, Haidong Yang, Meng Zhou, Jun Jiao, Yang Wang, Qin Petridis, Dimitris Sapalidis, Konstantinos Sardeli, Chrysanthi Konsta, Parthenopi Koulouris, Charilaos Michalopoulos, Nikolaos Giannakidis, Dimitrios Barbetakis, Nikolaos Katsaounis, Athanasios Hohenforst-Schmidt, Wolfgang Amaniti, Aikaterini Petanidis, Savvas Tsakiridis, Kosmas Courcoutsakis, Nikolaos Goganau, Alexandru Marian Vagionas, Anastasios Romanidis, Konstantinos Oikonomou, Panagoula Karanikas, Michael Katsios, Iason Nikolaos Kesisoglou, Isaak Kosmidis, Christoforos Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? |
title | Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? |
title_full | Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? |
title_fullStr | Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? |
title_full_unstemmed | Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? |
title_short | Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? |
title_sort | pleurodesis and immunotherapy in nsclc; medical thoracoscopy or vats? |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995373/ https://www.ncbi.nlm.nih.gov/pubmed/32047566 http://dx.doi.org/10.7150/jca.40004 |
work_keys_str_mv | AT zarogoulidispaul pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT huanghaidong pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT yangmeng pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT zhoujun pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT jiaoyang pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT wangqin pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT petridisdimitris pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT sapalidiskonstantinos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT sardelichrysanthi pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT konstaparthenopi pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT koulourischarilaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT michalopoulosnikolaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT giannakidisdimitrios pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT barbetakisnikolaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT katsaounisathanasios pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT hohenforstschmidtwolfgang pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT amanitiaikaterini pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT petanidissavvas pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT tsakiridiskosmas pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT courcoutsakisnikolaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT goganaualexandrumarian pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT vagionasanastasios pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT romanidiskonstantinos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT oikonomoupanagoula pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT karanikasmichael pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT katsiosiasonnikolaos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT kesisoglouisaak pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats AT kosmidischristoforos pleurodesisandimmunotherapyinnsclcmedicalthoracoscopyorvats |